Log in to save to my catalogue

RPN2-mediated glycosylation of tetraspanin CD63 regulates breast cancer cell malignancy

RPN2-mediated glycosylation of tetraspanin CD63 regulates breast cancer cell malignancy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4070641

RPN2-mediated glycosylation of tetraspanin CD63 regulates breast cancer cell malignancy

About this item

Full title

RPN2-mediated glycosylation of tetraspanin CD63 regulates breast cancer cell malignancy

Publisher

England: BioMed Central Ltd

Journal title

Molecular cancer, 2014-05, Vol.13 (1), p.134-134, Article 134

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

The tetraspanin CD63 is a highly N-glycosylated protein that is known to regulate cancer malignancy. However, the contribution of glycosylation of CD63 to cancer malignancy remains unclear. Previously, we reported that ribophorin II (RPN2), which is part of an N-oligosaccharyle transferase complex, is responsible for drug resistance in breast cance...

Alternative Titles

Full title

RPN2-mediated glycosylation of tetraspanin CD63 regulates breast cancer cell malignancy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4070641

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4070641

Other Identifiers

ISSN

1476-4598

E-ISSN

1476-4598

DOI

10.1186/1476-4598-13-134

How to access this item